ReBio

Oncology

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

News

FulcrumSec has reportedly offered data from a Novo Nordisk breach for sale after a $25m ransom was rejected, but has a second breach also occurred?

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.